Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Osteoporotic postmenopausal Sudanese women have a high risk of cardiovascular disease.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Finasteride may help some women with hair loss, but better options exist.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Balancing hormones can help women feel youthful and healthy.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Olive leaf extract may help reduce aging signs in postmenopausal women.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

EF and PXE not closely related.